查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375963

血流傳染病檢查市場規模、佔有率、趨勢分析報告：按產品類型、按樣本類型、按技術、按最終用途、按地區、按細分市場、預測，2023-2030 年

Bloodstream Infection Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Sample Type (Blood Culture), By Technology (PCR, ISH), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

血流傳染病檢查市場成長與趨勢：

Grand View Research, Inc.最新研究顯示，預計到2030年，全球血流傳染病檢查市場規模將達到9.7757億美元，年複合成長率為4.5%。

全球感染疾病數量的增加、人們對感染控制的認知不斷提高以及對感染控制的重視是推動市場發展的一些關鍵因素。例如，根據歐洲疾病預防控制中心（ECDC）2022年4月進行的流行病學調查，歐洲各地的耳念珠菌病例明顯增加。研究顯示，耳念珠菌報告病例顯著增加，從 2020 年 8 個國家報告的 335 例增加到 2021 年 13 個國家報告的 655 例。 2021 年報告的病例中有 15.3% 是血流感染疾病。

此外，市場主要企業不斷進步的技術進步和新產品的推出、政府的鼓勵配合措施以及對捐血重要性的認知不斷提高預計將推動市場成長。例如，2020 年 4 月。次世代定序儀公司 DNAe 因其創新的 LiDia-SEQ 平台和首次檢測獲得了美國食品藥物管理局(FDA) 的突破性設備稱號。這項指定將使 DNAe 能夠開發快速、經濟高效的檢測方法，用於感染疾病診斷、癌症、感染控制以及大流行的防範和應對。指定的檢測方法著重於感染疾病，特別是血流感染疾病（BSI）和抗菌素抗藥性（AMR），旨在直接從患者檢體中檢測和識別膿毒症相關感染疾病。這就是我的意思。透過突破性設備計劃，FDA 將提供持續的支援和協作互動，以加速 DNAe 的 LiDia-SEQ 定序系統和 BSI/AMR 測試的開發和商業化。

F. Hoffmann-La Roche Ltd、bioMerieux SA 和 BD 等市場主要企業正在實施併購策略，以增強其產品能力並加速其產品供應。例如，2021年5月，F. Hoffmann-La Roche Ltd以18億美元收購了GenMark Diagnostics。此次收購將擴大羅氏分子診斷產品的組合。同樣，2021年12月，該公司收購了TIB Molbiol Group。 TIB Molbiol 集團擁有約 45 種 CE-IVD核准的血液學檢測、遺傳基因檢測、感染疾病診斷和移植醫學檢測方法。

血流傳染病檢查市場報告亮點

  • 按產品分類，2022年試劑和消耗品領域佔市場最大銷售佔有率。由於捐贈者和接受者容易取得且頻繁購買篩檢產品，預計該細分市場在預測期內將以最快的速度成長。
  • 根據樣本類型，血液培養領域預計將在 2022 年佔據最大的收益佔有率，並在預測期內實現最快的年複合成長率。
  • 從技術角度來看，由於檢測需求不斷增加，PCR 領域預計將在 2022 年佔據市場最大的收益佔有率，並在預測期內以最快的年複合成長率成長。
  • 按最終用途分類，醫院和診斷中心細分市場在 2022 年佔據最大收益佔有率。
  • 北美主導了血流傳染病檢查市場，在 2022 年佔據了最大的收益佔有率。這是由於該地區可支配所得不斷增加、醫療基礎設施高度發展以及有利的報銷政策。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章 傳染病檢查市場：產品業務分析

  • 血流傳染病檢查市場：產品變異分析
  • 裝置
  • 試劑及消耗品

第5章 傳染病檢查市場：樣本類型的商業分析

  • 血流傳染病檢查市場：樣本類型變異分析
  • 全血
  • 血液培養

第6章 傳染病檢查市場：技術業務分析

  • 血流傳染病檢查市場：技術波動分析
  • PCR
  • 質譜
  • 原位雜合技術
  • 其他

第7章 傳染病檢查市場：最終用戶業務分析

  • 血流傳染病檢查市場：最終用戶波動分析
  • 醫院和診斷中心
  • 客製化實驗室服務提供商
  • 學術研究所
  • 其他

第8章 傳染病檢查市場：區域業務分析

  • 2022 年和 2030 年按地區分類的血流傳染病檢查市場佔有率
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章 傳染病檢查市場：競爭形勢

  • 參與企業
  • 參與企業概況
  • 2022 年公司市場佔有率分析
  • 策略規劃

第10章 分析師的觀點

Product Code: GVR-4-68040-140-3

Bloodstream Infection Testing Market Growth & Trends:

The global bloodstream infection testing market size is expected to reach USD 977.57 million by 2030, registering at a CAGR of 4.5%, according to a new study by Grand View Research, Inc. The increasing number of infectious diseases globally and the growing awareness and emphasis on infection control are some of the major factors driving the market. For Instance, according to an epidemiologic survey organized by the European Centre for Disease Prevention and Control (ECDC) in April 2022, there was a notable increase in Candida auris cases across the European region. The survey revealed a significant rise in reported cases of C. auris, from 335 cases reported by 8 countries in 2020 to 655 cases reported by 13 countries in 2021. Bloodstream infections accounted for 15.3% of the reported cases in 2021.

In addition, increasing technological advancements and new product launches by key companies in the market, encouraging government initiatives, and increasing awareness about the importance of blood donation are expected to propel market growth. For instance, in April 2020. DNAe, a next-generation sequencing company, has received a "Breakthrough Device" designation from the U.S. Food and Drug Administration (FDA) for its innovative LiDia-SEQ platform and first assay. This designation enables DNAe to develop rapid and cost-effective tests for infectious disease diagnostics, cancer, infection control, and pandemic preparedness and response. The designated assay focuses on infectious diseases, specifically bloodstream infections (BSI) and antimicrobial resistance (AMR), aiming to detect and identify infections associated with sepsis directly from patient specimens. Through the Breakthrough Device program, the FDA will provide ongoing support and collaborative interactions to facilitate the development and launch of DNAe's LiDia-SEQ sequencing system and BSI/AMR test.

The key players in the market, such as F. Hoffmann-La Roche Ltd., bioMerieux SA, BD, etc., are implementing the strategy of merger & acquisition to enhance product capabilities and promote their product offerings. For instance, in May 2021, F. Hoffmann-La Roche Ltd. completed the acquisition of GenMark Diagnostics for USD 1.8 billion. This acquisition would help Roche expand its molecular diagnostics portfolio. Similarly, in December 2021, the company acquired TIB Molbiol Group, which has around 45 CE-IVD-approved assays for hematology testing, inherited genetic testing, diagnosing infectious diseases, and transplant medicine.

Bloodstream Infection Testing Market Report Highlights:

  • Based on the product, the reagents and consumables segment accounted for the largest revenue share of the market in 2022. The segment is also expected to grow at the fastest rate over the forecast period owing to the easy availability and frequent purchase of screening products for donors and recipients
  • Based on sample type, the blood culture segment accounted for the largest revenue share in 2022 and is expected to witness the fastest CAGR over the forecast period
  • Based on technology, the PCR segment held the largest revenue share of the market in 2022 and is expected to grow with the fastest CAGR over the forecast period owing to increasing demand for the tests
  • Based on end-user, the hospital and diagnostic centers segment accounted for the largest revenue share in 2022
  • North America dominated the bloodstream infection testing market and accounted for the largest revenue share in 2022. This is due to the region's Increasing disposable income, highly developed health infrastructure, and favorable reimbursement policies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Sample Type segment
      • 1.1.1.2. Product segment
      • 1.1.1.3. Technology segment
      • 1.1.1.4. End-use segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product and Sample Type Snapshot
  • 2.3. Technology and End-use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of infectious diseases
      • 3.2.1.2. Technological advancements in bloodstream infection testing
      • 3.2.1.3. Growing initiatives for blood donations campaign
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High diagnosis cost and lower investments in underdeveloped countries
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bloodstream Infection Testing Market: Product Business Analysis

  • 4.1. Bloodstream Infection Testing Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Reagents and Consumables
    • 4.3.1. Reagents and Consumables Market, 2018 - 2030 (USD Million)

Chapter 5. Bloodstream Infection Testing Market: Sample Type Business Analysis

  • 5.1. Bloodstream Infection Testing Market: Sample Type Movement Analysis
  • 5.2. Whole Blood
    • 5.2.1. Whole Blood Market, 2018 - 2030 (USD Million)
  • 5.3. Blood Culture
    • 5.3.1. Blood Culture Market, 2018 - 2030 (USD Million)

Chapter 6. Bloodstream Infection Testing Market: Technology Business Analysis

  • 6.1. Bloodstream Infection Testing Market: Technology Movement Analysis
  • 6.2. PCR
    • 6.2.1. PCR Market, 2018 - 2030 (USD Million)
  • 6.3. Mass Spectroscopy
    • 6.3.1. Mass Spectroscopy Market, 2018 - 2030 (USD Million)
  • 6.4. In Situ Hybridization
    • 6.4.1. In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Bloodstream Infection Testing Market: End-User Business Analysis

  • 7.1. Bloodstream Infection Testing Market: End-User Movement Analysis
  • 7.2. Hospitals & Diagnostic Centers
    • 7.2.1. Hospitals & Diagnostics Centers Market, 2018 - 2030 (USD Million)
  • 7.3. Custom Laboratory Service Providers
    • 7.3.1. Custom Laboratory Service Providers Market, 2018 - 2030 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Bloodstream Infection Testing Market: Regional Business Analysis

  • 8.1. Bloodstream Infection Testing Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. U.S. Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Canada Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. Reimbursement Scenario
      • 8.3.2.6. UK Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. France Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. Italy Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Spain Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Denmark Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Sweden Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Norway Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Reimbursement Scenario
      • 8.4.2.6. Japan Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. China Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. India Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. Australia Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. Thailand Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. South Korea Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Reimbursement Scenario
      • 8.5.2.6. Brazil Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Mexico Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Reimbursement Scenario
      • 8.5.4.6. Argentina Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Reimbursement Scenario
      • 8.6.2.6. South Africa Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. Saudi Arabia Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. UAE Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. Kuwait Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)

Chapter 9. Bloodstream Infection Testing Market: Competitive Landscape

  • 8.1. Participant Categorization
    • 9.1.1. bioMerieux SA
      • 9.1.1.1. Overview
      • 9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.1.3. Product Benchmarking
      • 9.1.1.4. Strategic Initiatives
    • 9.1.2. BD
      • 9.1.2.1. Overview
      • 9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.2.3. Product Benchmarking
      • 9.1.2.4. Strategic Initiatives
    • 9.1.3. Cepheid
      • 9.1.3.1. Overview
      • 9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.3.3. Product Benchmarking
      • 9.1.3.4. Strategic Initiatives
    • 9.1.4. Seegene Inc.
      • 9.1.4.1. Overview
      • 9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.4.3. Product Benchmarking
      • 9.1.4.4. Strategic Initiatives
    • 9.1.5. T2 Biosystems, Inc.
      • 9.1.5.1. Overview
      • 9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.5.3. Product Benchmarking
      • 9.1.5.4. Strategic Initiatives
    • 9.1.6. F. Hoffmann-La Roche Ltd
      • 9.1.6.1. Overview
      • 9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.6.3. Product Benchmarking
      • 9.1.6.4. Strategic Initiatives
    • 9.1.7. Siemens Healthcare Limited
      • 9.1.7.1. Overview
      • 9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.7.3. Product Benchmarking
      • 9.1.7.4. Strategic Initiatives
    • 9.1.8. Luminex Corporation
      • 9.1.8.1. Overview
      • 9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.8.3. Product Benchmarking
      • 9.1.8.4. Strategic Initiatives
    • 9.1.9. Bruker
      • 9.1.9.1. Overview
      • 9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.9.3. Product Benchmarking
      • 9.1.9.4. Strategic Initiatives
    • 9.1.10. Accelerate Diagnostics, Inc.
      • 9.1.10.1. Overview
      • 9.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.10.3. Product Benchmarking
      • 9.1.10.4. Strategic Initiatives
  • 9.2. Participant's Overview
  • 9.3. Financial Performance
  • 9.4. Product Benchmarking
  • 9.5. Company Market Share Analysis, 2022
  • 9.6. Strategy Mapping
    • 9.6.1. Expansion
    • 9.6.2. Acquisition
    • 9.6.3. Product/Service Launch
    • 9.6.4. Others

Chapter 10. Analyst View

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Bloodstream Infection Testing Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Global Bloodstream Infection Testing Market, By Sample type, 2018 - 2030 (USD Million)
  • Table 5 Global Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Bloodstream Infection Testing Market, By End-user, 2018 - 2030 (USD Million)
  • Table 7 Global Bloodstream Infection Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Bloodstream Infection Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Bloodstream Infection Testing Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Bloodstream Infection Testing Market, By Sample type, 2018 - 2030 (USD Million)
  • Table 11 North America Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 17 Canada Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 19 Canada Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 20 Canada Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD million)
  • Table 21 Europe Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Europe Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 24 Europe Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 25 Europe Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 UK Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 27 UK. Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 28 UK Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 29 UK Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 30 Germany Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 32 Germany Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 33 Germany Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 34 France Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 35 France Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 36 France Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 France Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Italy Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Italy Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 40 Italy Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Italy Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Spain Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Spain Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 44 Spain Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 45 Spain Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 46 Denmark Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Denmark Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 Denmark Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 Sweden Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Sweden Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 52 Sweden Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Sweden Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 Norway Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Norway Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 56 Norway Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Norway Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 Japan Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Japan Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 65 Japan Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Japan Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 67 China Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 68 China Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 69 China Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 China Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 71 India Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 72 India Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 73 India Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 India Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 75 Australia Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 76 Australia Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 77 Australia Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Australia Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 79 Thailand Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 80 Thailand Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 81 Thailand Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Thailand Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 83 South Korea Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 84 South Korea Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 85 South Korea Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Korea Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Latin America Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Latin America Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 90 Latin America Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 Latin America Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 92 Brazil Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Brazil Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 94 Brazil Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Brazil Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 96 Mexico Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Mexico Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 98 Mexico Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 99 Mexico Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 102 Argentina Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Argentina Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 112 South Africa Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 117 UAE Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 118 UAE Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 119 UAE Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 120 UAE Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Microscope software, market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT analysis
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Global bloodstream infection testing market: product movement & market share analysis.
  • Fig. 16 Global bloodstream infection testing market, for reagents and consumables, 2018 - 2030 (USD Million)
  • Fig. 17 Global bloodstream infection testing market, for instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global bloodstream infection testing market: Sample type movement & market share analysis.
  • Fig. 19 Global bloodstream infection testing market, for whole blood, 2018 - 2030 (USD Million)
  • Fig. 20 Global bloodstream infection testing market, for blood culture, 2018 - 2030 (USD Million)
  • Fig. 21 Global bloodstream infection testing market: Technology movement & market share analysis.
  • Fig. 22 Global bloodstream infection testing market, for PCR, 2018 - 2030 (USD Million)
  • Fig. 23 Global bloodstream infection testing market, for mass spectroscopy, 2018 - 2030 (USD Million)
  • Fig. 24 Global bloodstream infection testing market, for in situ hybridization, 2018 - 2030 (USD Million)
  • Fig. 25 Global bloodstream infection testing market, for others, 2018 - 2030 (USD Million)
  • Fig. 26 Global bloodstream infection testing market: End-use movement & market share analysis.
  • Fig. 27 Global bloodstream infection testing market, for end-use, movement & market share analysis.
  • Fig. 28 Global bloodstream infection testing market, for hospitals & diagnostic centers, 2018 - 2030 (USD Million)
  • Fig. 29 Global bloodstream infection testing market, for custom laboratory service providers, 2018 - 2030 (USD Million)
  • Fig. 30 Global bloodstream infection testing market, for academic & research institutes, 2018 - 2030 (USD Million)
  • Fig. 31 Global bloodstream infection testing market, for others, 2018 - 2030 (USD Million)
  • Fig. 32 Regional marketplace: key takeaways
  • Fig. 33 Regional outlook, 2022 & 2030
  • Fig. 34 Global bloodstream infection testing market: region movement analysis.
  • Fig. 35 North America bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. key country dynamics
  • Fig. 37 U.S. bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada key country dynamics
  • Fig. 39 Canada bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 41 UK key country dynamics
  • Fig. 42 UK bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany key country dynamics
  • Fig. 44 Germany bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 45 France key country dynamics
  • Fig. 46 France bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy key country dynamics
  • Fig. 48 Italy bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain key country dynamics
  • Fig. 50 Spain bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark key country dynamics
  • Fig. 52 Denmark bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden key country dynamics
  • Fig. 54 Sweden bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 55 Norway key country dynamics
  • Fig. 56 Norway bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 58 Japan key country dynamics
  • Fig. 59 Japan bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 60 China key country dynamics
  • Fig. 61 China bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 64 Australia key country dynamics
  • Fig. 65 Australia bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand key country dynamics
  • Fig. 67 Thailand bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea key country dynamics
  • Fig. 69 South Korea bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil key country dynamics
  • Fig. 72 Brazil bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 73 Mexico key country dynamics
  • Fig. 74 Mexico bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina key country dynamics
  • Fig. 76 Argentina bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 77 Middle East and Africa bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa key country dynamics
  • Fig. 79 South Africa bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia key country dynamics
  • Fig. 81 Saudi Arabia bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 82 UAE key country dynamics
  • Fig. 83 UAE bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait key country dynamics
  • Fig. 85 Kuwait bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 86 Company market position analysis
  • Fig. 87 Company/competition categorization
  • Fig. 88 Strategy mapping